Transgenics can substantially reduce capital investment and lower production costs through economies of scale and more flexible scale-up.
Nancy Markley
Advertisement
Nancy Markley, PhD is director of business development at SemBioSys Genetics Inc.
Articles by Nancy Markley
Advertisement
Latest Updated Articles
Producing Proteins Using Transgenic Oilbody-Oleosin TechnologyPublished: June 1st 2006 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
